EU could approve Pfizer-BioNTech and Moderna vaccines in December

News Desk

The President of the European Commission, Ursula von der Leyen has announced that the European Union (EU) is set to approve both the Pfizer-BioNTech and Moderna vaccines before the end of the year. It means they could then be distributed across the bloc.

According to Russia Today report, Ursula von der Leyen has made the announcement in a press conference after a video summit of EU leaders on Friday.

The Commission President said, “If all the procedures go smoothly, the EMA [European Medicines Agency] could give the Moderna Pfizer/BioNTech vaccines their conditional marketing authorization as early as the second half of December.”

Ursula von der Leyen has said that Russia’s Sputnik V vaccine could potentially be used in member states if it is subjected to the same EMA authorization procedure as other vaccine candidates.

It is to be mentioned here that after approval, EU has agreed deals with five companies to distribute coronavirus vaccines across the continent, including AstraZeneca, CureVac, Johnson & Johnson, Pfizer-BioNTech and Sanofi-GSK.